Hangzhou SDIC Microelectronics (SH:688130)2023-09-27 02:04Group 1: Company Overview - The company is Hangzhou Jinghua Microelectronics Co., Ltd., with stock code 688130 and abbreviation Jinghua Micro [1] - The investor relations activity took place on September 22, 2023, in an offline meeting format [2] Group 2: Revenue Breakdown - In the first half of 2023, the revenue from medical health SoC chip products accounted for 57.46%, a year-on-year decrease of 13.33% [3] - Revenue from industrial control and instrumentation chip products represented 41.07%, showing a year-on-year increase of 10.83% [3] - Revenue from intelligent perception SoC chip products was 1.47%, with a significant year-on-year growth of 51.93% [3] Group 3: New Product Launches - In the first half of 2023, the company launched several new products, including high-performance pressure/temperature sensor signal conditioning chips and specialized SoC chips for blood pressure and blood glucose meters [3] - Upcoming products include high-performance eight-electrode body fat scale SoC chips and various other specialized chips, with several high-speed and high-resolution ADC chips expected to be mass-produced by the end of 2023 [3] Group 4: Competitive Advantages - The company's core technological advantages lie in its self-developed high-precision Sigma-Delta ADC SoC technology and low-power, high-interference resistance capabilities in industrial control chips, which are considered advanced domestically [4] - The company also emphasizes integrated solutions and rapid local response to customer feedback [4] Group 5: Client Relationships - Major clients for medical health SoC chips include Xiangshan Weighing Apparatus, Lexin Medical, and Wolai Technology; for industrial control and instrumentation chips, clients include Yuli De, Huashengchang, and Victory Instruments [4] - The company has been actively expanding its market presence and has made progress in collaborations with well-known brands in products like thermometers and uric acid meters [4] Group 6: R&D and Performance Goals - As of June 2023, the company had 124 R&D personnel, reflecting a year-on-year increase of 65.33% [4] - The company has launched a restricted stock incentive plan for 2023, aiming to increase market share and scale, with a target gross margin of 64.14% for the first half of 2023 [4]